The study of systemic influence by chemotherapy in elderly patients with lung cancer

The study of systemic influence by chemotherapy in elderly patients with lung cancer - The study of systemic influence by chemotherapy in elderly patients with lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022594

Enrollment

Registered

2016-06-05

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. lung cancer patients 2. stage IIIB or IV 3. the patients who recieve chemotherapy in our hospital. 4. adequate organ functions 5. obtained written informed consent

Exclusion criteria

Exclusion criteria: 1. significant severe diseases 2. active infection 3. symptomatic brain metastases 4. mental or psychological disorder 5. history of severe allergic reaction to any medication 6. in pregnancy 7. patients who judged to be inappropriate by the attending doctor

Design outcomes

Primary

Measure	Time frame
The comparison of the lung, heart, liver,and renal functions before and after chemotherapy	—

Secondary

Measure	Time frame
The assessment of quality of life	—

Countries

Japan

Contacts

Public ContactTatsuo Kimura

Osaka City University Premier Preventive Medicine

kimutats@med.osaka-cu.ac.jp06-6624-4041

Outcome results